Skip to Main Content

Author Details

Fabrice Lucien
Mayo Clinic
2010
53
18
PMIDPaper TitleJournal TitlePublished Year
36821432The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors.Neuro Oncol2023
37967193Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8<sup>+</sup> T cells via ME1 up-regulation.Sci Adv2023
37662200Nanoprojectile Secondary Ion Mass Spectrometry Enables Multiplexed Analysis of Individual Hepatic Extracellular Vesicles.bioRxiv2023
37414595Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery.Urol Oncol2023
37429047Visible light-induced 3D bioprinted injectable scaffold for minimally invasive tissue regeneration.Biomater Adv2023
37163328A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma.J Immunol2023
36745503Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities.Oncologist2023
34739560Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy.Cancer Immunol Immunother2022
35551087Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy.BMJ Open2022
35383410Assessment of extracellular vesicle isolation methods from human stool supernatant.J Extracell Vesicles2022
35770741Calibration and standardization of extracellular vesicle measurements by flow cytometry for translational prostate cancer research.Nanoscale2022
35671867Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity.Int J Radiat Oncol Biol Phys2022
35395000Poly (ADP-Ribose) and α-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.PLoS One2022
35751046Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer.BMC Urol2022
35552651Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.Clin Cancer Res2022
36712192Three-Dimensional Ultrasound Localization Microscopy with Bipartite Graph-Based Microbubble Pairing and Kalman-Filtering-Based Tracking on a 256-Channel Verasonics Ultrasound System with a 32⿿ÿ⿿32 Matrix Array.J Med Biol Eng2022
35878715Radiation Therapy in Oligometastatic Prostate Cancer.Int J Radiat Oncol Biol Phys2022
35157705Chorioallantoic membrane (CAM) assay to study treatment effects in diffuse intrinsic pontine glioma.PLoS One2022
34911739NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.Cancer Immunol Res2022
33468358Improved Ultrasound Microvessel Imaging Using Deconvolution with Total Variation Regularization.Ultrasound Med Biol2021
33652418Fast super-resolution ultrasound microvessel imaging using spatiotemporal data with deep fully convolutional neural network.Phys Med Biol2021
33498666Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man's Trash Is Another Man's Treasure.Cancers (Basel)2021
34769075Deciphering Evolutionary Dynamics and Lineage Plasticity in Aggressive Prostate Cancer.Int J Mol Sci2021
34593526Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer.Clin Cancer Res2021
34119742Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model.Nucl Med Biol2021
34284799Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.Cell Commun Signal2021
34355211A size-exclusion-based approach for purifying extracellular vesicles from human plasma.Cell Rep Methods2021
33388419Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia.Mol Ther2021
32305910In Vivo Confocal Imaging of Fluorescently Labeled Microbubbles: Implications for Ultrasound Localization Microscopy.IEEE Trans Ultrason Ferroelectr Freq Control2020
34296200Decreased gremlin 1 expression in women with BMI ⿥35 kg/m<sup>2</sup> is mediated by interleukin 10 and interleukin 1β in the follicular fluid.F S Sci2020
32080744The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.Neuro Oncol2020
32051485Ultrasound localization microscopy of renal tumor xenografts in chicken embryo is correlated to hypoxia.Sci Rep2020
32574624IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.Gastroenterology2020
30647137The role of extracellular vesicles in cancer microenvironment and metastasis: myths and challenges.Biochem Soc Trans2019
31497744Characterization of Cellular Sources and Circulating Levels of Extracellular Vesicles in a Dietary Murine Model of Nonalcoholic Steatohepatitis.Hepatol Commun2019
31433301Integrin β<sub>1</sub>-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH.J Hepatol2019
31475741Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients.Prostate2019
30987640RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.J Transl Med2019
30894634Noninvasive Contrast-Free 3D Evaluation of Tumor Angiogenesis with Ultrasensitive Ultrasound Microvessel Imaging.Sci Rep2019
30800217Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases.Oncotarget2019
29190494FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.Neoplasia2018
30250892Targeting endosomal pH for cancer chemotherapy.Mol Cell Oncol2018
30112749Analytical Considerations in Nanoscale Flow Cytometry of Extracellular Vesicles to Achieve Data Linearity.Thromb Haemost2018
29511618Suboptimal extracellular pH values alter DNA damage response to induced double-strand breaks.FEBS Open Bio2018
28762517Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples.Prostate2017
28635961Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance.Nat Commun2017
27822355Erratum to: Increased microenvironment stiffness in damaged myofibers promotes myogenic progenitor cell proliferation.Skelet Muscle2016
25729564Increased microenvironment stiffness in damaged myofibers promotes myogenic progenitor cell proliferation.Skelet Muscle2015
26388987Erratum to: Increased microenvironment stiffness in damaged myofibers promotes myogenic progenitor cell proliferation.Skelet Muscle2015
24798000Simultaneous pH measurement in endocytic and cytosolic compartments in living cells using confocal microscopy.J Vis Exp2014
  • 1 - 50 of 53

Recommended Authors

Andrew Macklin
Margaret Cancer Center
Career Start Year 2016
Number of shared co-authors 4
Sheila Spada
Weill Cornell Medical College
Career Start Year 2014
Number of shared co-authors 0
Mara Gilardi
Institute of Medical Genetics and Pathology.
Career Start Year 2014
Number of shared co-authors 0
Kien Pham
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 0
Ankit Sinha
Max Planck Institute of Biochemistry
Career Start Year 2011
Number of shared co-authors 2
Paola A Guerrero
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 1
Leonora Balaj
Massachusetts General Hospital
Career Start Year 2010
Number of shared co-authors 0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 1
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 1
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Henrik J Johansson
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 0
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Trevor D McKee
University Health Network
Career Start Year 2001
Number of shared co-authors 2
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 4
David T Miyamoto
Massachusetts General Hospital
Career Start Year 2000
Number of shared co-authors 1
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Dolores Di Vizio
Cedars-Sinai Medical Center
Career Start Year 1997
Number of shared co-authors 1
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Peter Kuhn
University of Tubingen
Career Start Year 1994
Number of shared co-authors 1
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 1
Edwin M Posadas
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 1
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 2
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 0
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 2
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 1
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 3

Collaborators

Hon S Leong
University of Toronto
Co-authored papers 7
Brian A Costello
The Mayo Clinic
Co-authored papers 5
Matthew R Lowerison
University of Illinois at Urbana-Champaign
Co-authored papers 4
Lance C Pagliaro
Mayo Clinic
Co-authored papers 3
Daniel D Billadeau
Co-authored papers 2
Bradley J Stish
Mayo Clinic
Co-authored papers 2
Surendra Dasari
Mayo Clinic
Co-authored papers 1
Alan H Bryce
Mayo Clinic
Co-authored papers 1
David S Knopman
Mayo Clinic Rochester
Co-authored papers 1
Michelle Meringer
Sunnybrook Research Institute
Co-authored papers 1
Christianne Hoey
Evaluative Clinical Sciences, Sunnybrook Research Institute
Co-authored papers 1
Hu Li
Co-authored papers 1
C Richard Choo
Mayo Clinic
Co-authored papers 1
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 1
Thomas M Pisansky
Mayo Clinic
Co-authored papers 1
Bradley F Boeve
Mayo Clinic Rochester
Co-authored papers 1
Joseph L Chin
University of Western Ontario
Co-authored papers 1
Brian J Davis
Mayo Clinic
Co-authored papers 1
Stanley K Liu
Odette Cancer Centre, University of Toronto
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Shulan Tian
Co-authored papers 1
Masanori Fukushima
Nagasaki University Graduate School of Biomedical Sciences
Co-authored papers 1
Robert W Williams
Mayo Clinic
Co-authored papers 1
Krishna S Nair
Co-authored papers 1
Cristina Correia
Co-authored papers 1
Gregory N Ruegsegger
University of Wisconsin-River Falls
Co-authored papers 1
Jeffrey L Winters
Mayo Clinic
Co-authored papers 1
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 1
Jessica Ray
Sunnybrook Research Institute, University of Toronto
Co-authored papers 1
Ali H Zahalka
Co-authored papers 1
Release 1.2